AR and pachyonychia congenita: For example the aneuploid populations with adverse histological features and multiple selected genomic aberrations including a 5.7N population with high level AR amplification that arose during the clinical history of a patient who developed advanced PC, were uniquely sensitive to therapeutic regimen and were erased after hormone withdrawal (Figure 8).